MSN Laboratories Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Sy. No. 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Mandal),, Sangareddy District, Telangana 502329, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3005254981 · DUNS 863363165
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-03-31
- NAIDrug Quality Assurance2019-12-20
- VAIDrug Quality Assurance2018-03-09
- VAIDrug Quality Assurance2015-02-06
- NAIDrug Quality Assurance2012-03-09
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- DapagliflozinCipla USA Inc.
- PosaconazoleLupin Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.